LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1015

Search options

  1. Article ; Online: Determination of serum aflatoxin B

    Di Gregorio, Mayra Carraro / Jager, Alessandra Vincenzi / Souto, Pollyana Cristina Maggio Castro / Costa, Aline Alves / Rottinghaus, George Edwin / Passarelli, Danielle / Budiño, Fabio Enrique Lemos / Corassin, Carlos Humberto / Oliveira, Carlos Augusto Fernandes

    Mycotoxin research

    2017  Volume 33, Issue 2, Page(s) 93–102

    Abstract: In this study, serum aflatoxin B ...

    Abstract In this study, serum aflatoxin B
    MeSH term(s) Adsorption ; Aflatoxin B1/blood ; Aflatoxin B1/isolation & purification ; Aluminum Silicates ; Animal Feed ; Animals ; Diet/methods ; Food Additives ; Food Contamination ; Lysine/blood ; Mycotoxins/blood ; Mycotoxins/isolation & purification ; Serum/chemistry ; Swine
    Chemical Substances Aluminum Silicates ; Food Additives ; Mycotoxins ; sodium calcium aluminosilicate, hydrated (1344-01-0) ; Aflatoxin B1 (9N2N2Y55MH) ; Lysine (K3Z4F929H6)
    Language English
    Publishing date 2017-05
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 14500-2
    ISSN 1867-1632 ; 0178-7888
    ISSN (online) 1867-1632
    ISSN 0178-7888
    DOI 10.1007/s12550-016-0267-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections.

    Thomas, Konstantinos / Tsioulos, Georgios / Kotsogianni, Christina / Banos, Agellos / Niemela, Julie E / Cheng, Aristine / DiMaggio, Tom / Holland, Steven / Rosenzweig, Sergio D / Tziolos, Nikolaos / Papadopoulos, Antonios / Lionakis, Michail S / Boumpas, Dimitrios T

    RMD open

    2023  Volume 9, Issue 2

    Abstract: ... interferon-γ, whole exome sequencing revealed a homozygous polymorphism in the NF-kappa-B essential modulator ...

    Abstract Infections are among the most serious complications in patients with systemic lupus erythematosus (SLE), with bacterial and viral infections being the most common. Non-tuberculous mycobacterial (NTM) infections are quite rare and are typically seen in older patients with SLE with longstanding disease duration treated with corticosteroids. Here, we describe a 39-year-old woman with SLE and an unusual pattern of recurrent NTM disseminated infections. After excluding the presence of autoantibodies against interferon-γ, whole exome sequencing revealed a homozygous polymorphism in the NF-kappa-B essential modulator (NEMO) gene. Primary immunodeficiencies should be included in the differential diagnosis of patients with recurrent opportunistic infections, even in those with iatrogenic immunosuppression.
    MeSH term(s) Adult ; Female ; Humans ; Autoantibodies ; Immunosuppression Therapy ; Lupus Erythematosus, Systemic/complications ; Lupus Erythematosus, Systemic/diagnosis ; Lupus Erythematosus, Systemic/drug therapy ; Nontuberculous Mycobacteria ; Polymorphism, Genetic
    Chemical Substances Autoantibodies
    Language English
    Publishing date 2023-06-25
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 2812592-7
    ISSN 2056-5933 ; 2056-5933
    ISSN (online) 2056-5933
    ISSN 2056-5933
    DOI 10.1136/rmdopen-2023-003149
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: NF-kappa-B essential modulator (NEMO) gene polymorphism in an adult woman with systemic lupus erythematosus and recurrent non-tuberculous mycobacterial disseminated infections

    Antonios Papadopoulos / Nikolaos Tziolos / Aristine Cheng / Georgios Tsioulos / Konstantinos Thomas / Christina Kotsogianni / Agellos Banos / Julie E. Niemela / Tom DiMaggio / Steven Holland / Sergio D. Rosenzweig / Michail S. Lionakis / Dimitrios T. Boumpas

    RMD Open, Vol 9, Iss

    2023  Volume 2

    Abstract: ... interferon-γ, whole exome sequencing revealed a homozygous polymorphism in the NF-kappa-B essential modulator ...

    Abstract Infections are among the most serious complications in patients with systemic lupus erythematosus (SLE), with bacterial and viral infections being the most common. Non-tuberculous mycobacterial (NTM) infections are quite rare and are typically seen in older patients with SLE with longstanding disease duration treated with corticosteroids. Here, we describe a 39-year-old woman with SLE and an unusual pattern of recurrent NTM disseminated infections. After excluding the presence of autoantibodies against interferon-γ, whole exome sequencing revealed a homozygous polymorphism in the NF-kappa-B essential modulator (NEMO) gene. Primary immunodeficiencies should be included in the differential diagnosis of patients with recurrent opportunistic infections, even in those with iatrogenic immunosuppression.
    Keywords Medicine ; R
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher BMJ Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy

    Luca Castagna / Roberto Bono / Stefania Tringali / Giuseppe Sapienza / Alessandra Santoro / Alessandro Indovina / Vittoria Tarantino / Laura Di Noto / Aurelio Maggio / Caterina Patti

    Frontiers in Medicine, Vol

    2022  Volume 9

    Abstract: ... large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and ... ALLO-SCT and CAR-T-cell therapy in patients with aggressive lymphomas (large B-cell lymphoma and MCL ...

    Abstract Chimeric antigen receptor T (CAR-T) cells are a treatment option for patients with relapse/refractory (R/R) non-Hodgkin lymphoma (NHL), acute lymphoid leukemia and multiple myeloma. To date, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL) have been successfully treated with CAR-T cells directed against the CD19 antigen. However, when R/R disease persists after several treatment lines, patients with these diseases are often referred to transplantation centres to receive allogeneic stem cell transplantation (ALLO-SCT). ALLO-SCT and CAR-T cells share mechanism of actions, inducing immune effects of T-cells (and other cells after transplantation) against lymphoma cells, but they differ in several other characteristics. These differences justify unique positioning of each therapy within treatment algorithms. In this paper, we analyzed the results obtained after ALLO-SCT and CAR-T-cell therapy in patients with aggressive lymphomas (large B-cell lymphoma and MCL) to identify the ideal scenarios in which these 2 immunological therapies should be employed.
    Keywords allogeneic stem cell transplantation ; CAR-T cells therapy ; non-Hodgkin lymphoma ; refractory ; toxicity ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2022-12-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: UV light absorption parameters of the pathobiologically implicated bilirubin oxidation products, MVM, BOX A, and BOX B.

    Harris, Nathaniel A / Rapoport, Robert M / Zuccarello, Mario / Maggio, John E

    Data in brief

    2018  Volume 18, Page(s) 1400–1409

    Abstract: ... dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide ...

    Abstract The formation of the bilirubin oxidation products (BOXes), BOX A ([4-methyl-5-oxo-3-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide), as well as MVM (4-methyl-3-vinylmaleimide) were synthesized by oxidation of bilirubin with H
    Language English
    Publishing date 2018-04-12
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2786545-9
    ISSN 2352-3409
    ISSN 2352-3409
    DOI 10.1016/j.dib.2018.04.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Murine norovirus inhibits B cell development in the bone marrow of STAT1-deficient mice.

    Hsu, Charlie C / Meeker, Stacey M / Escobar, Sabine / Brabb, Thea L / Paik, Jisun / Park, Heon / Iritani, Brian M / Maggio-Price, Lillian

    Virology

    2017  Volume 515, Page(s) 123–133

    Abstract: ... that noroviruses can infect B cells. We demonstrate that murine norovirus (MNV) infection can significantly impair ... B cell development in the bone marrow in a signal transducer and activator of transcription 1 (STAT1 ... in the absence of STAT1 in ex vivo cultured B cells. Interestingly, using bone marrow transplantation studies ...

    Abstract Noroviruses are a leading cause of gastroenteritis in humans and it was recently revealed that noroviruses can infect B cells. We demonstrate that murine norovirus (MNV) infection can significantly impair B cell development in the bone marrow in a signal transducer and activator of transcription 1 (STAT1) dependent, but interferon signaling independent manner. We also show that MNV replication is more pronounced in the absence of STAT1 in ex vivo cultured B cells. Interestingly, using bone marrow transplantation studies, we found that impaired B cell development requires Stat1
    MeSH term(s) Animals ; B-Lymphocytes/metabolism ; B-Lymphocytes/virology ; Bone Marrow/metabolism ; Bone Marrow/virology ; Caliciviridae Infections/metabolism ; Caliciviridae Infections/virology ; Female ; Gastroenteritis/metabolism ; Gastroenteritis/virology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Norovirus/genetics ; Norovirus/physiology ; STAT1 Transcription Factor/deficiency ; STAT1 Transcription Factor/genetics ; Virus Replication
    Chemical Substances STAT1 Transcription Factor ; Stat1 protein, mouse
    Keywords covid19
    Language English
    Publishing date 2017-12-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 200425-2
    ISSN 1096-0341 ; 0042-6822
    ISSN (online) 1096-0341
    ISSN 0042-6822
    DOI 10.1016/j.virol.2017.12.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Fibrin-associated diffuse large B-cell lymphoma in a hemorrhagic cranial arachnoid cyst.

    Kirschenbaum, Daniel / Prömmel, Peter / Vasella, Flavio / Haralambieva, Eugenia / Marques Maggio, Ewerton / Reisch, Robert / Beer, Marc / Camenisch, Ulrike / Rushing, Elisabeth J

    Acta neuropathologica communications

    2017  Volume 5, Issue 1, Page(s) 60

    Language English
    Publishing date 2017--07
    Publishing country England
    Document type Letter
    ZDB-ID 2715589-4
    ISSN 2051-5960 ; 2051-5960
    ISSN (online) 2051-5960
    ISSN 2051-5960
    DOI 10.1186/s40478-017-0463-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial.

    Allais, Gianni / D'Andrea, Giovanni / Maggio, Maurizio / Benedetto, Chiara

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

    2013  Volume 34 Suppl 1, Page(s) S161–3

    Abstract: In this open trial we evaluated the possible efficacy of Ginkgolide B in the treatment of acute ...

    Abstract In this open trial we evaluated the possible efficacy of Ginkgolide B in the treatment of acute aura in a group of patients suffering from migraine with aura, considering in particular the effect of the treatment on aura duration. Twenty-five patients (16 females, 9 males, mean age 39.7 ± 13.5 years, range 18-65) suffering from migraine with aura were enrolled in the study. The diagnosis was made according to the diagnostic criteria of the international classification of headache disorders, second edition (ICHD-II), for typical aura with migraine headache (n = 19) or typical aura without headache (n = 6). Patients were asked to use a diary card to register the exact duration of the aura symptoms in two consecutive attacks of aura. In the first one, they only took note of the duration of neurological symptoms in minutes. In the following attack, they were instructed to take orally, immediately at the onset of the first symptoms of aura, two capsules of a combination of 60 mg Ginkgo biloba terpenes phytosome, 11 mg coenzyme Q 10 and 8.7 mg vitamin B2 (Migrasoll). Aura duration (expressed in minutes) was significantly (p < 0.001) reduced by Migrasoll intake, being 33.6 ± 11.5 in the first untreated attack and 21.9 ± 11.8 during the second attack. In general, there was a marked amelioration of the features of the neurological symptoms of aura in the treated attack. In four patients (18.1 %) suffering from typical aura with migraine, the pain phase disappeared. Among the patients who completed the study no serious adverse events were reported.
    MeSH term(s) Adolescent ; Adult ; Aged ; Female ; Fibrinolytic Agents/therapeutic use ; Ginkgolides/therapeutic use ; Humans ; Lactones/therapeutic use ; Male ; Middle Aged ; Migraine with Aura/drug therapy ; Young Adult
    Chemical Substances Fibrinolytic Agents ; Ginkgolides ; Lactones ; ginkgolide B (DF149B9460)
    Language English
    Publishing date 2013-05-22
    Publishing country Italy
    Document type Clinical Trial ; Journal Article
    ZDB-ID 2016546-8
    ISSN 1590-3478 ; 1590-1874
    ISSN (online) 1590-3478
    ISSN 1590-1874
    DOI 10.1007/s10072-013-1413-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Identification and quantification of bisphenol A and bisphenol B in polyvinylchloride and polycarbonate medical devices by gas chromatography with mass spectrometry.

    Gimeno, Pascal / Spinau, Coline / Lassu, Nelly / Maggio, Annie-Françoise / Brenier, Charlotte / Lempereur, Laurent

    Journal of separation science

    2015  Volume 38, Issue 21, Page(s) 3727–3734

    Abstract: ... medical devices. In order to assay, in addition to plasticizers, bisphenols A and B possibly present ... for the polyvinylchloride sample was tested and validated for the assay of bisphenols A and B in polycarbonate ... medical devices. The separation of all compounds, including bisphenols A and B, is obtained on a cross-linked 5 ...

    Abstract A gas chromatography with mass spectrometry method has already been developed and published for the identification and quantification of 14 phthalates and five nonphthalate plasticizers in polyvinylchloride medical devices. In order to assay, in addition to plasticizers, bisphenols A and B possibly present in polyvinylchloride samples, this previous method was extended to the assay of these additional potential endocrine disruptors. Furthermore, as bisphenol A could also be present in polycarbonate samples, the method used for the polyvinylchloride sample was tested and validated for the assay of bisphenols A and B in polycarbonate medical devices. The separation of all compounds, including bisphenols A and B, is obtained on a cross-linked 5%-phenyl/95%-dimethylpolysiloxane capillary column using a temperature gradient. For both plastics, samples are dissolved in tetrahydrofuran followed by a precipitation of the plastic by addition of ethanol. Results obtained point out residual bisphenol A amounts for polycarbonate samples ranging from 0.6 to 0.8% and for polyvinylchloride samples less or equal to 5 ppm. No bisphenol B was detected in the samples tested. For bisphenols A and B, mean recoveries obtained on spiked polyvinylchloride or polycarbonate sample preparations ranged from 87 to 108% in accordance with in-house specification (80-110%).
    MeSH term(s) Benzhydryl Compounds/analysis ; Chromatography, High Pressure Liquid/methods ; Diterpenes, Abietane/analysis ; Equipment and Supplies ; Gas Chromatography-Mass Spectrometry ; Ginsenosides/analysis ; Lignin/analysis ; Phenols/analysis ; Polycarboxylate Cement/chemistry ; Polyvinyl Chloride/chemistry ; Tandem Mass Spectrometry/methods
    Chemical Substances Benzhydryl Compounds ; Diterpenes, Abietane ; Ginsenosides ; Phenols ; Polycarboxylate Cement ; tanshinone (03UUH3J385) ; bisphenol B (1RC731TJJA) ; polycarbonate (25766-59-0) ; Polyvinyl Chloride (9002-86-2) ; Lignin (9005-53-2) ; bisphenol A (MLT3645I99)
    Language English
    Publishing date 2015-11
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2047990-6
    ISSN 1615-9314 ; 1615-9306
    ISSN (online) 1615-9314
    ISSN 1615-9306
    DOI 10.1002/jssc.201500552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: UV light absorption parameters of the pathobiologically implicated bilirubin oxidation products, MVM, BOX A, and BOX B

    Nathaniel A. Harris / Robert M. Rapoport / Mario Zuccarello / John E. Maggio

    Data in Brief, Vol 18, Iss , Pp 1400-

    2018  Volume 1409

    Abstract: ... dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide ... estimated using NMR) for BOX A, BOX B, and MVM in H2O, 15% CH3CN plus 10 mM CF3CO2H, CH3CN, CHCl3, CH2Cl2 ... by the solvent, ranging from 295–297 nm; 2) BOX B, less polar solvent yielded λmax's of lower wavelength ...

    Abstract The formation of the bilirubin oxidation products (BOXes), BOX A ([4-methyl-5-oxo-3-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide]) and BOX B (3-methyl-5-oxo-4-vinyl-(1,5-dihydropyrrol-2-ylidene)acetamide), as well as MVM (4-methyl-3-vinylmaleimide) were synthesized by oxidation of bilirubin with H2O2 without and with FeCl3, respectively. Compound identity was confirmed with NMR and mass spectrometry (MS; less than 1 ppm, tandem MS up to MS4). UV absorption profiles, including λmax, and extinction coefficient (ε; estimated using NMR) for BOX A, BOX B, and MVM in H2O, 15% CH3CN plus 10 mM CF3CO2H, CH3CN, CHCl3, CH2Cl2, and 0.9% NaCl were determined. At longer wavelengths, λmax's for 1) BOX A were little affected by the solvent, ranging from 295–297 nm; 2) BOX B, less polar solvent yielded λmax's of lower wavelength, with values ranging from 308–313 nm, and 3) MVM, less polar solvent yielded λmax's of higher wavelength, with values ranging from 318–327 nm. Estimated ε’s for BOX A and BOX B were approximately 5- to 10-fold greater than for MVM. Keywords: Bilirubin oxidation products, BOX A, BOX B, MVM, λmax, Extinction coefficient, Synthesis
    Keywords Computer applications to medicine. Medical informatics ; R858-859.7 ; Science (General) ; Q1-390
    Subject code 660
    Language English
    Publishing date 2018-06-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top